Russia sets price for anti-Convidian vaccine

In a press proposal, the head of the board of directors of the R-Pharm company, which is also the Russian company that claims to have discovered the vaccine against COVID-19-, Alexei Repik, has discovered that the Russian vaccine price for koronobrus, for the international market, will initially be at least $10 per two doses. “The prize do [...]
In a press proposal, the head of the board of directors of the R-Pharm company, which is also the Russian company that claims to have discovered the vaccine against COVID-19-, Alexei Repik, has discovered that the Russian vaccine price for koronobrus, for the international market, will initially be at least $10 per two doses.
The price will be at least $10 per two doses for the export market”, Alexei told Russia-24 television channel.
He said the price will change in the future, if the production of the vaccine reaches a sufficient industrial degree. At that, Russia is the first country so far to have announced the creation of a vaccine against the new coronary.
This fact has sparked international debate, since the World Health Organization and other powerful states view the vaccine with scepticism and suspicion.











